Full Text View
Tabular View
No Study Results Posted
Related Studies
Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula
This study has been completed.
Study NCT00040313   Information provided by Eyetech Pharmaceuticals
First Received: June 24, 2002   Last Updated: May 2, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Macular Edema
Additional conditions recognized in this trial
Edema
Macular Edema
More general conditions related to this trial
Eye Diseases
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Signs and Symptoms
Interventions listed in this trial
pegaptanib sodium (Macugen)
Sponsors listed in this trial
Eyetech Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services